According to Fuji Pharma latest financial reports the cash on hand of 4554 is $14.79M, an decrease of -34.46% to 2022. At the end of 2022 company had $22.56M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $14.79M | -34.46% |
2022 | $22.56M | -65.23% |
2021 | $64.90M | -15.30% |
2020 | $76.62M | 41.76% |
2019 | $54.05M | 35.88% |
2018 | $39.78M | - |